Literature DB >> 26659909

Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.

Kristian Krpina1, Emina Babarović2, Josip Španjol3, Gordana Đorđević2, Tobias Maurer4, Nives Jonjić2.   

Abstract

OBJECTIVE: The aim of the present study was to correlate the level of tumor-infiltrating immune cells with bladder cancer size and T category in patients with solitary low-grade non-muscle invasive bladder cancer (NMIBC). PATIENTS AND METHODS: Between 1996 and 2006, 115 patients with solitary low-grade NMIBC after transurethral resection of the bladder without adjuvant therapy were retrospectively identified from the institutional database. Tumor specimens were retrieved and tissue microarrays were constructed. Immunhistochemical staining for tumor-infiltrating immune cells with anti-CD3, CD4, CD8, CD20, CD56, CD68, and granzyme B (Gr B) was performed.
RESULTS: Immune cells were predominantly observed within the cancer stroma. Statistically significant higher levels of CD56 cells in small tumors and CD68 cells in T1 tumors (p = 0.0310, 0.0151, respectively) were established.
CONCLUSION: The current study propose a possible correlation of CD56+ and CD68+ cells with bladder cancer size and stage in patients with solitary low-grade NMIBC.

Entities:  

Keywords:  NK cells; T category; macrophages; non-muscle invasive bladder cancer; tumor microenviroment; tumor size

Mesh:

Substances:

Year:  2015        PMID: 26659909     DOI: 10.1007/s00508-015-0907-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  23 in total

1.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

Authors:  Kiavash Movahedi; Damya Laoui; Conny Gysemans; Martijn Baeten; Geert Stangé; Jan Van den Bossche; Matthias Mack; Daniel Pipeleers; Peter In't Veld; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

2.  Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Authors:  Tommaso Cai; Gabriella Nesi; Vieri Boddi; Sandra Mazzoli; Maurizio Dal Canto; Riccardo Bartoletti
Journal:  Oncol Rep       Date:  2006-08       Impact factor: 3.906

Review 3.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Authors:  Marko Babjuk; Maximilian Burger; Richard Zigeuner; Shahrokh F Shariat; Bas W G van Rhijn; Eva Compérat; Richard J Sylvester; Eero Kaasinen; Andreas Böhle; Joan Palou Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

4.  Prognostic value of tumor-associated macrophage count in human bladder cancer.

Authors:  T Hanada; M Nakagawa; A Emoto; T Nomura; N Nasu; Y Nomura
Journal:  Int J Urol       Date:  2000-07       Impact factor: 3.369

5.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

Review 6.  Human natural killer cells: origin, receptors, function, and clinical applications.

Authors:  Lorenzo Moretta; Elisa Montaldo; Paola Vacca; Genny Del Zotto; Francesca Moretta; Pietro Merli; Franco Locatelli; Maria Cristina Mingari
Journal:  Int Arch Allergy Immunol       Date:  2014-08-26       Impact factor: 2.749

Review 7.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

Authors:  Chrysoula I Liakou; Sowmita Narayanan; Derek Ng Tang; Christopher J Logothetis; Padmanee Sharma
Journal:  Cancer Immun       Date:  2007-06-26

8.  Factors affecting recurrence and progression in superficial bladder tumours.

Authors:  K H Kurth; L Denis; C Bouffioux; R Sylvester; F M Debruyne; M Pavone-Macaluso; W Oosterlinck
Journal:  Eur J Cancer       Date:  1995-10       Impact factor: 9.162

9.  Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates.

Authors:  Kyong Yeun Jung; Sun Wook Cho; Young A Kim; Daein Kim; Byung-Chul Oh; Do Joon Park; Young Joo Park
Journal:  J Pathol Transl Med       Date:  2015-07-15

10.  PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk.

Authors:  Francesco Mariani; Paola Sena; Giulia Magnani; Stefano Mancini; Carla Palumbo; Maurizio Ponz de Leon; Luca Roncucci
Journal:  ScientificWorldJournal       Date:  2013-11-14
View more
  4 in total

1.  Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations.

Authors:  Jie Zhi; Zhongxin Li; Jian Lv; Bo Feng; Donghai Yang; Liang Xue; Zhaolong Zhao; Yanni Zhang; Jianhua Wu; Yingchao Jv; Yitao Jia
Journal:  Oncol Lett       Date:  2018-01-10       Impact factor: 2.967

2.  Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.

Authors:  Margarida Ferreira-Teixeira; Daniela Paiva-Oliveira; Belmiro Parada; Vera Alves; Vitor Sousa; Obinna Chijioke; Christian Münz; Flávio Reis; Paulo Rodrigues-Santos; Célia Gomes
Journal:  BMC Med       Date:  2016-10-21       Impact factor: 8.775

Review 3.  Immune escape mechanisms and immunotherapy of urothelial bladder cancer.

Authors:  Zhao Yang; Yinyan Xu; Ying Bi; Nan Zhang; Haifeng Wang; Tianying Xing; Suhang Bai; Zongyi Shen; Faiza Naz; Zichen Zhang; Liqi Yin; Mengran Shi; Luyao Wang; Lei Wang; Shihui Wang; Lida Xu; Xin Su; Song Wu; Changyuan Yu
Journal:  J Clin Transl Res       Date:  2021-07-30

4.  Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA.

Authors:  Zexi He; Jun Gu; Ting Luan; Haihao Li; Charles Li; Zhenjie Chen; Enxiu Luo; Jiansong Wang; Yinglong Huang; Mingxia Ding
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.